Tuesday, May 5, 2026

Latest
Honda Freezes $11 Billion EV Plant in Canada, Project Cancellation On The Table
Agnico Eagle Makes Waves: Avenir Minerals Acquires Fox River in Unexpected $94.3M Phosphate Play
Canadian Oil Pipeline to Wyoming Secures 400,000 bpd in Shipper Pledges
Romania Plunges Into Chaos as 281 Lawmakers Vote Out Pro-EU Prime Minister
Republicans Demand $1 Billion for Trump Ballroom Security Upgrades
Questcorp’s La Union Surface Program Delivers 20 g/t Gold Over 2.9 Metres In Channel Sample
Cameco Sees Realized Uranium Prices Climb to US$66 a Pound in Q1
Two Dead in Blast at Kazakhstan’s Largest Zinc Plant Owned by Glencore
Coinbase Cuts 14% of Employees, Bets on AI to Redefine Crypto Exchange
Canada’s Wealth Gap Hits Five-Year High as Stock Gains Bypass Most Households
Search

Satipharm’s Phase 1 clinical trial results.

Satipharm's Phase 1 clinical trial results.

Satipharm’s Phase 1 clinical trial results.

© 2026
the deep dive
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.